The Trump administration's ongoing war on 'DEI' (diversity, equity, and inclusion) has now extended its destructive reach to Alzheimer's research, leaving scientists and researchers in a state of confusion and frustration. This latest round of grant cancellations at Emory University and the University of Pittsburgh highlights a disturbing pattern of political interference in scientific inquiry, particularly those exploring the impact of racism and discrimination on brain health.
The cancellations, which represent millions of dollars in lost funding, are not just a blow to the researchers involved but also to the broader scientific community. Ann Cohen, an associate professor of psychiatry at the University of Pittsburgh, expresses her dismay, stating, 'This kind of clear political interference – that’s not a good way to do science.' The fact that these grants were canceled due to their focus on the impacts of racism is particularly concerning, as it suggests a deliberate attempt to silence research that challenges certain narratives.
What makes this situation even more intriguing is the administration's previous attempts to disrupt scientific research. In the spring of 2025, billions of dollars in federal grants with perceived connections to 'DEI' were canceled, leading to lawsuits from major research institutions. While a federal judge initially ruled these cancellations illegal, the Trump administration managed to overturn this decision through a shadow docket ruling from the Supreme Court. This raises the question: is the administration now employing a new legal strategy, one that is more legally defensible but still just as damaging to scientific progress?
The cancellations at Emory and Pittsburgh are particularly noteworthy due to the nature of the research. At Emory, Negar Fani's grant studied the impact of racial discrimination on the white matter of the brain, using surveys, wearable devices, MRIs, and data fusion analysis. Fani highlights the importance of self-reported measures, stating, 'Those perceptions get under the skin, into the brain, and affect in real ways health.' This type of research is crucial for understanding the complex relationship between discrimination and brain health, yet it has been deemed 'not scientifically valid' by the NIH.
At Pittsburgh, Andrea Rosso's grant explored how Alzheimer's disease risk is affected in people living in divested, predominantly African American neighborhoods. Rosso emphasizes that they do not measure structural racism directly but use it as a framing device to understand the high risk in certain populations. The cancellation of this grant, along with Cohen's, suggests a broader attempt to silence research that challenges the notion of individual responsibility for health outcomes, even when influenced by systemic factors.
The NIH's director, Dr. Jay Bhattacharya, provides a seemingly plausible explanation for the cancellations, citing the lack of 'concrete, objective, and measurable variables' in the research. However, as Cohen points out, this assertion demonstrates a lack of understanding of the research methods employed in epidemiology. The use of self-reported measures is a common and scientifically valid approach in many fields, and to dismiss it as 'not scientifically valid' is to ignore the complexity of human experience and the limitations of objective measures.
The impact of these cancellations extends beyond the researchers and institutions involved. It raises questions about the future of scientific inquiry and the role of political interference in shaping research agendas. It also highlights the importance of diversity and inclusion in scientific research, as these fields often grapple with issues of bias and inequality. The Trump administration's war on 'DEI' is not just a threat to scientific progress but also to the very values that underpin the pursuit of knowledge and understanding.
In my opinion, the cancellations of these grants are a clear example of how political ideology can be used to silence scientific inquiry. The administration's pattern of targeting research that challenges certain narratives is concerning and should be met with resistance from the scientific community and the public alike. The future of Alzheimer's research and the broader scientific enterprise depends on our ability to protect the integrity of scientific inquiry from political interference.
